TY - JOUR
T1 - Pretreatment mri radiomics based response prediction model in locally advanced cervical cancer
AU - Gui, Benedetta
AU - Autorino, Rosa
AU - Miccò, Maura
AU - Nardangeli, Alessia
AU - Pesce, Adele
AU - Lenkowicz, Jacopo
AU - Cusumano, Davide
AU - Russo, Luca
AU - Persiani, Salvatore
AU - Boldrini, Luca
AU - Dinapoli, Nicola
AU - Macchia, Gabriella
AU - Sallustio, Giuseppina
AU - Gambacorta, Maria Antonietta
AU - Ferrandina, Gabriella
AU - Manfredi, Riccardo
AU - Valentini, Vincenzo
AU - Scambia, Giovanni
N1 - Funding Information:
We would like to thank Franziska M. Lohmeyer, Fondazione Policlinico Universitario A. Gemelli IRCCS, for her support revising our manuscript.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/4
Y1 - 2021/4
N2 - The aim of this study was to create a radiomics model for Locally Advanced Cervical Cancer (LACC) patients to predict pathological complete response (pCR) after neoadjuvant chemora-diotherapy (NACRT) analysing T2-weighted 1.5 T magnetic resonance imaging (MRI) acquired before treatment start. Patients with LACC and an International Federation of Gynecology and Obstetrics stage from IB2 to IVA at diagnosis were retrospectively enrolled for this study. All patients underwent NACRT, followed by radical surgery; pCR—assessed on surgical specimen—was defined as absence of any residual tumour. Finally, 1889 features were extracted from MR images; features showing statistical significance in predicting pCR at the univariate analysis were selected following an iterative method, which was ad-hoc developed for this study. Based on this method, 15 different classifiers were trained considering the most significant features selected. Model selection was carried out using the area under the receiver operating characteristic curve (AUC) as target metrics. One hundred eighty-three patients from two institutions were analysed. The model, showing the highest performance with an AUC of 0.80, was the random forest method initialised with default parameters. Radiomics appeared to be a reliable tool in pCR prediction for LACC patients undergoing NACRT, supporting the identification of patient risk groups, which paves treatment pathways tailored according to the predicted outcome.
AB - The aim of this study was to create a radiomics model for Locally Advanced Cervical Cancer (LACC) patients to predict pathological complete response (pCR) after neoadjuvant chemora-diotherapy (NACRT) analysing T2-weighted 1.5 T magnetic resonance imaging (MRI) acquired before treatment start. Patients with LACC and an International Federation of Gynecology and Obstetrics stage from IB2 to IVA at diagnosis were retrospectively enrolled for this study. All patients underwent NACRT, followed by radical surgery; pCR—assessed on surgical specimen—was defined as absence of any residual tumour. Finally, 1889 features were extracted from MR images; features showing statistical significance in predicting pCR at the univariate analysis were selected following an iterative method, which was ad-hoc developed for this study. Based on this method, 15 different classifiers were trained considering the most significant features selected. Model selection was carried out using the area under the receiver operating characteristic curve (AUC) as target metrics. One hundred eighty-three patients from two institutions were analysed. The model, showing the highest performance with an AUC of 0.80, was the random forest method initialised with default parameters. Radiomics appeared to be a reliable tool in pCR prediction for LACC patients undergoing NACRT, supporting the identification of patient risk groups, which paves treatment pathways tailored according to the predicted outcome.
KW - Cervical cancer
KW - MRI
KW - Pathological response
KW - Prediction model
KW - Radiomics
UR - http://www.scopus.com/inward/record.url?scp=85109019818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109019818&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11040631
DO - 10.3390/diagnostics11040631
M3 - Article
AN - SCOPUS:85109019818
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 4
M1 - 631
ER -